AstraZeneca Resumes U.S. COVID-19 Vaccine Trial And Next Week J&J Prepares To Do Same - Coronavirus Updates

AstraZeneca Plc has resumed the U.S. trial of its experimental COVID19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday.

Read More >>